Literature DB >> 31880362

Ozone alleviates ischemia/reperfusion injury by inhibiting mitochondrion-mediated apoptosis pathway in SH-SY5Y cells.

Hua-An Cai1, Xi Tao2, Li-Jun Zheng2, Liang Huang2, Yan Peng3, Ruo-Yi Liao4, Yi-Min Zhu5.   

Abstract

Cerebral ischemia/reperfusion (I/R) injuries are common and often cause severe complications. Ozone has been applied for protecting I/R injury in animal models of several organs including cerebra, but the detailed mechanism remains unclear. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and lactate dehydrogenase measurement were used to determine the influence of ozone on cell activity and damage of SH-SY5Y cells. Some redox items such as catalase (CAT), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were measured by enzyme-linked immunosorbent assay. The mitochondrial membrane potential (ΔΨm ) was determined by JC-1 assay. Cytochrome-c (cyt-c) level in the cytoplasm and mitochondrion was measured by western blotting. Apoptosis was determined by flow cytometry, and some apoptosis-related molecules were detected by quantitative real-time polymerase chain reaction and western blotting. Ozone alleviated oxidative damage by increasing GSH-Px, SOD, CAT, and decreasing MDA. Ozone decreased mitochondrial damage caused by I/R injury and inhibited the release of cyt-c from mitochondrion to cytoplasm in SH-SY5Y cells. The cell apoptosis caused by I/R was inhibited by ozone, and ozone could decrease apoptosis by increasing the ratio of Bcl-2/Bax and inhibiting caspase signaling pathway in SH-SY5Y cells. Ozone has the ability of maintaining redox homeostasis, decreasing mitochondrion damage, and inhibiting neurocytes apoptosis induced by I/R. Therefore, ozone may be a promising protective strategy against cerebral I/R injury.
© 2019 International Federation for Cell Biology.

Entities:  

Keywords:  cell apoptosis; cerebral ischemia/reperfusion; mitochondrial damage; ozone

Mesh:

Substances:

Year:  2020        PMID: 31880362     DOI: 10.1002/cbin.11294

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  Relationship of ozone application and time in rats with hypoxic-ischemic brain injury.

Authors:  B Resitoglu; C Yalcın; M Komur; A Polat; S Erdogan; H Beydagi
Journal:  Hippokratia       Date:  2021 Apr-Jun       Impact factor: 0.522

Review 2.  Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.

Authors:  Salvatore Chirumbolo; Luigi Valdenassi; Vincenzo Simonetti; Dario Bertossi; Giovanni Ricevuti; Marianno Franzini; Sergio Pandolfi
Journal:  Int Immunopharmacol       Date:  2021-05-11       Impact factor: 5.714

Review 3.  Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages.

Authors:  Xing Chang; Wenjin Zhang; Zhenyu Zhao; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Lei Zhang; Yuping Zhao
Journal:  Front Cell Dev Biol       Date:  2020-12-23

4.  Do pyroptosis, apoptosis, and necroptosis (PANoptosis) exist in cerebral ischemia? Evidence from cell and rodent studies.

Authors:  Wei-Tao Yan; Yan-Di Yang; Xi-Min Hu; Wen-Ya Ning; Lyu-Shuang Liao; Shuang Lu; Wen-Juan Zhao; Qi Zhang; Kun Xiong
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

5.  The Relationship between Ozone and Human Blood in the Course of a Well-Controlled, Mild, and Transitory Oxidative Eustress.

Authors:  Gerardo Tricarico; Valter Travagli
Journal:  Antioxidants (Basel)       Date:  2021-12-04

6.  Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis.

Authors:  Yujie Chen; Zhiying Fan; Qingwei Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.